Patient information: Lichen sclerosus (Beyond the Basics)
- Susan M Cooper, MB ChB, MRCGP, FRCP, MD
Susan M Cooper, MB ChB, MRCGP, FRCP, MD
- Consultant Dermatologist and Honorary Senior Clinical Lecturer
- Oxford University Hospitals
- Stephanie J Arnold, FACD, MBBS (Hons), BSc (Hons)
Stephanie J Arnold, FACD, MBBS (Hons), BSc (Hons)
- Honorary Consultant
- Churchill Hospital Department of Dermatology, Oxford
- Section Editors
- Robert L Barbieri, MD
Robert L Barbieri, MD
- Editor-in-Chief — Obstetrics, Gynecology and Women's Health
- Section Editor — General Gynecology and Female Reproductive Endocrinology
- Kate Macy Ladd Professor of Obstetrics, Gynecology and Reproductive Biology
- Harvard Medical School
- Jeffrey Callen, MD, FACP, FAAD
Jeffrey Callen, MD, FACP, FAAD
- Editor-in-Chief — Dermatology
- Section Editor — Skin and Systemic Disease
- Professor of Medicine
- University of Louisville School of Medicine
Lichen sclerosus (LS) is a skin disorder that causes the skin to become thin, whitened, and wrinkled, and can cause itching and pain. LS usually occurs in postmenopausal women, although men, children, and premenopausal women may be affected. It can develop on any skin surface, but in women it most commonly occurs near the clitoris, on the labia (the inner and outer genital lips), and in the anal region (figure 1). In 15 to 20 percent of patients, LS lesions develop on other skin surfaces, such as the thighs, breasts, wrists, shoulders, neck, and even inside the mouth.
It is not clear exactly how many people have LS. Estimates for LS involving the female genitals vary from 1 in 30 older adult women seen in general gynecology offices to 1 in 300 to 1000 patients referred to dermatologists.
LICHEN SCLEROSUS CAUSES AND RISK FACTORS
The cause of lichen sclerosus (LS) is not clear; healthcare providers suspect that a number of factors may be involved.
Genetic factors — LS seems to be more common in some families. People who are genetically predisposed to LS may develop symptoms after experiencing trauma, injury, or sexual abuse.
Disorders of the immune system — LS in females may be an autoimmune disorder, in which the body's immune system mistakenly attacks and injures the skin. People with LS are at greater risk of developing other autoimmune disorders, such as some types of thyroid disease, anemia, diabetes, alopecia areata, and vitiligo .
Infections — Researchers have tried to identify an infectious organism as a cause of LS, but no clear data have shown that there is an infectious source . LS is not contagious.
LICHEN SCLEROSUS (LS) SIGNS AND SYMPTOMS
Features of genital LS in women — Some women with genital LS feel dull, painful discomfort in the vulva, while other women have no symptoms. The most common symptoms include:
●Vulvar itching – The most common symptom of LS is itching. It may be so severe that it interferes with sleep.
●Anal itching, fissures, bleeding, and pain – (See "Patient information: Anal fissure (Beyond the Basics)".)
●Painful sexual intercourse (dyspareunia) – This can occur as a result of repeated cracking of the skin (fissuring) or from narrowing of the vaginal opening due to scarring.
Typically, women with genital LS have thin, white, wrinkled skin on the labia, often extending down and around the anus (figure 1). Purple-colored areas of bruising may be seen. Cracks (also known as fissures) may form in the skin in the area around the anus, the labia, and the clitoris. Relatively minor rubbing or sex may lead to bleeding due to the fragility of the involved skin.
If genital LS is not treated, it may progress and change the appearance of the genital area as the outer and inner lips of the vulva fuse (stick together) and cover the clitoris. The opening of the vagina can become narrowed, and cracks, fissures, and thickened, scarred skin in the genital and anal area can make sexual intercourse or genital examination painful. LS does not affect the inner reproductive organs, such as the vagina and uterus.
Features of genital LS in men — In men, LS may appear on the head of the penis. Men who develop LS are usually uncircumcised (they have not had the foreskin of the penis removed), and the foreskin can become tight, shrunken, and scarred over the head of the penis. Men with LS may also have problems pulling back the foreskin and may experience decreased sensation at the tip of the penis, painful erections, or problems with urination .
Features of LS in other areas — LS may also cause lesions to occur in areas outside the genitals, especially the upper body, breasts, and upper arms. These lesions tend to be white, flat or raised, and are not as itchy as the affected skin of the genitals and anus.
LICHEN SCLEROSUS DIAGNOSIS
Providers typically use the following methods to diagnose lichen sclerosus (LS).
History and physical examination — A medical history and physical examination of the vulvar and anal areas will be done, looking for the signs and symptoms of LS.
Biopsy — To confirm a suspected diagnosis of LS, a biopsy is recommended. A small piece of the affected skin will be removed and sent to a pathologist to be examined with a microscope.
Excluding other conditions — Tests may be done to exclude other conditions that could cause symptoms similar to those of LS, such as:
●Lichen planus (a skin disease that can also cause itching and fusing of genital skin). Lichen planus can occur together with LS.
●Low estrogen level (a lack of the hormone estrogen can rarely cause fusing of genital skin but is often the cause of painful intercourse). (See "Patient information: Vaginal dryness (Beyond the Basics)".)
●Vitiligo (a disorder that can cause white skin patches similar to those of LS). Vitiligo can occur together with LS.
●Pemphigoid (a blistering skin disorder that also causes scarring of the vulva) is extremely rare.
●Hemorrhoids (which can also cause cracks in the skin of the anus).
LS and cancer — Women with LS affecting the vulva are at a slightly increased risk for developing squamous cell skin cancer.
Diagnosing genital LS early, treating it effectively, and biopsying any abnormal areas may help to reduce the risk of developing or missing a diagnosis of skin cancer. A once-yearly examination of the skin of the vulva is recommended, and women should examine themselves regularly for lumps or sores that do not heal. A biopsy should be performed if there are areas that do not improve with treatment.
LS lesions outside the genital area do not have an increased risk of cancer. Men with LS that affects the skin of the penis have an increased risk of squamous cell skin cancer of the penis.
LS and painful sexual intercourse — LS can lead to constriction of the vaginal opening and pain during sexual intercourse. Women who experience pain during sex first require treatment to suppress any active disease. Once the disease is controlled, some clinicians may recommend an estrogen cream to help to soften the skin around the vaginal opening. Devices called vaginal dilators, which patients can use at home, also may be used to slowly stretch the skin.
Pain with intercourse can also occur from other causes. Patients who notice pain during intercourse should discuss their symptoms with their healthcare providers.
LICHEN SCLEROSUS TREATMENT
The goals of treatment of lichen sclerosus (LS) are to relieve bothersome symptoms and to prevent the condition from worsening. A clinician may recommend medication for the physical symptoms, and may refer the patient for support and therapy for other issues associated with the condition, such as problems with sex.
All patients with genital LS, even those without noticeable symptoms, need to use medication on a regular and ongoing basis. Patients also should see a healthcare provider for reevaluation of the disease at least once or twice yearly.
Patients who are diagnosed with genital LS should talk to their clinician about:
●The lifelong and potentially progressive nature of LS; appropriate treatment can stop the condition from worsening
●Ways to manage the condition
●The slightly increased risk of vulvar cancer and the need for ongoing monitoring
●How to keep the genital area healthy and avoid scratching (table 1)
●Persistent pain with intercourse
Depending on the severity of the condition, a healthcare provider may recommend one or more of the following treatments for genital LS:
●Steroid ointments are recommended to reduce inflammation and itching. Strong steroid ointments (eg, clobetasol propionate) are the mainstay of treatment for genital LS and are effective in the majority of women. Initial treatment usually requires daily application of the ointment for one to three months to resolve the symptoms and reduce inflammation. After the initial course, most women require "maintenance" therapy with either less frequent application of the strong steroid ointment or a switch to a less potent steroid. Although there may be warnings on the product about the use of topical steroids on genital skin, it is important to use an adequate amount to bring the disease under control. The healthcare provider will provide guidance about the amount to use and frequency of application.
●Steroid injections, especially if steroid ointments are not effective.
Steroids are the treatment of choice for genital LS. Occasionally, medications called topical calcineurin inhibitors (eg, tacrolimus or pimecrolimus) are prescribed for patients who respond poorly to steroids or cannot tolerate steroid treatment.
Oral or topical tricyclic antidepressants (TCAs) are sometimes recommended for vulvar pain that persists despite steroids. The dose of TCAs is typically much lower than that used for treating depression. It is believed that these drugs reduce pain perception when used in low doses, although it is not clear how TCAs work.
TCAs commonly used for pain management include amitriptyline, desipramine, and nortriptyline. Patients beginning TCAs commonly experience fatigue; this is not always an undesirable side effect, since it can help improve sleep when TCAs are taken in the evening. TCAs are generally started in low doses and increased gradually. Their full effect may not be seen for weeks to months.
Although it is not approved by the US Food and Drug Administration (FDA) for this use, an oral medication called acitretin has also been used for the treatment of LS in some patients [4,5]. Because it has many side effects, including a risk for liver damage, the drug is used primarily in patients who have not been helped by other treatments. Acitretin can cause severe birth defects, and women should not get pregnant during treatment or for three years after taking the drug. For this reason, acitretin usually is not recommended for women of child-bearing age.
For women with LS involving the genitalia, surgery may be used to treat consequences of the disease, such as abnormal fusion of tissues or scarring. It is important to continue medical treatment after surgery to prevent the recurrence of scarring.
Men who have genital LS are generally treated with circumcision, which removes the foreskin of the penis. After circumcision, LS does not usually come back.
WHAT TO EXPECT
The good news for patients who have been diagnosed with lichen sclerosus (LS) is that treatments such as topical steroid ointments are very effective. Thus, early treatment of LS with topical steroids can prevent scarring. Follow-up is important throughout the lifetime.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our website (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Vulvar lesions: Differential diagnosis based on morphology
Epidemiology and risk factors for cutaneous squamous cell carcinoma
Vulvar cancer: Clinical manifestations, diagnosis, and pathology
Vulvar intraepithelial neoplasia
Vulvar lichen planus
Vulvar lichen sclerosus
Vulvovaginal complaints in the prepubertal child
Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)
Extragenital lichen sclerosus
The following organizations also provide reliable health information.
●National Institute of Arthritis and Musculoskeletal and Skin Diseases
●National Lichen Sclerosus Support Group
●National Vulvodynia Association
- Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.
- Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004; 17:28.
- Questions and Answers about Lichen Sclerosus. National Institute of Arthritis and Musculoskeletal and Skin Diseases 2004. Available at: www.niams.nih.gov/hi/topics/lichen/lichen.htm (Accessed on November 06, 2008).
- Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30:225.
- Ioannides D, Lazaridou E, Apalla Z, et al. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. J Urol 2010; 183:1395.
- Kunstfeld R, Kirnbauer R, Stingl G, Karlhofer FM. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139:850.
- Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004; 140:702.
- Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004; 140:709.
All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.